• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Akoya BioSciences, Inc. - Common Stock (NQ:AKYA)

1.290 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Akoya BioSciences, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Akoya Biosciences Reports First Quarter 2025 Financial Results
May 12, 2025
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA
May 07, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Quanterix and Akoya Biosciences Announce Amended Merger Agreement
April 29, 2025
From Quanterix Corporation
Via Business Wire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PPBI, SSBK, AKYA on Behalf of Shareholders
April 24, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Pacific Premier Bancorp, Inc. (Nasdaq - PPBI), Southern States Bancshares, Inc. (Nasdaq - SSBK), Akoya Biosciences, Inc. (Nasdaq - AKYA)
April 24, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025
April 24, 2025
ADC assay now available through ABS; customer study proves IO60 is a spatial workhorse 
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas
April 24, 2025
>8,500 samples and 100 million cells of high resolution and fully annotated spatial proteomics data available 
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore
April 23, 2025
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AKYA, CKPT, QTRX on Behalf of Shareholders
April 17, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, SLRN, AKYA, SHYF on Behalf of Shareholders
April 07, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities
April 02, 2025
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
March 17, 2025
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels
February 05, 2025
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK, ACCD, ESSA, AKYA on Behalf of Shareholders
January 11, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA
January 10, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Shareholder Alert: Ademi LLP Investigates Whether Akoya Biosciences, Inc. Is Obtaining a Fair Price for Its Public Shareholders
January 10, 2025
From Ademi LLP
Via Business Wire
News headline image
AKYA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akoya Biosciences, Inc. Is Fair to Shareholders
January 10, 2025
From Halper Sadeh LLC
Via Business Wire
News headline image
Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers
January 10, 2025
From Quanterix Corporation
Via Business Wire
News headline image
Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions
December 10, 2024
Akoya expands clinical test menu, exclusively licensing the global rights to develop and commercialize NeraCare's Immunoprint test for prognostication of disease recurrence in early-stage melanoma... 
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone
December 09, 2024
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences Reports Third Quarter 2024 Financial Results
November 14, 2024
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode™ Discovery IO60 and Mouse FFPE IO Panel
November 05, 2024
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024
October 28, 2024
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy
October 07, 2024
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors
October 03, 2024
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences Reports Second Quarter 2024 Financial Results
August 05, 2024
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences
July 15, 2024
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences Reports First Quarter 2024 Financial Results
May 13, 2024
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
May 09, 2024
Leveraging Akoya’s market-leading PhenoImager HT platform and clinical development expertise with NeraCare’s Immunoprint test and best-in-class clinical data, the partnership will focus on increasing... 
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
May 06, 2024
From Akoya Biosciences, Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap